2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$54.07-$0.29 (-0.53%)
Price as of Jun 23, 2026 7:07 PM EDT- $5.4BMarket Cap
- 19.34%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$54.07-$0.29 (-0.53%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.36 | ||
Change | +$0.27 (+0.50%) | ||
Open | $54.85 | ||
High | $56.08 | ||
Low | $54.08 | ||
Previous Close | $54.09 | ||
Volume | 1,135,637 | ||
30-Day Average Volume | 1,702,037 | ||
1-Week Change | 3.33% | ||
1-Month Change | 7.94% | ||
1-Year Change | 19.34% | ||
3-Year Change | -4.53% | ||
5-Year Change | -57.93% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.4B | ||
Enterprise Value | $5.5B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$122.9M | ||
Free Cash Flow | -$109.4M | ||
EBIT | -$121.5M | ||
EBITDA | -$117.2M | ||
Net Working Capital | $2.3B | ||
EPS | -$1.28 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 5,522 | ||
P/B | 3 | ||
P/E | -42 | ||
PEG | -6 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue